Physicians and researchers in the Kidney Tumor Program work with colleagues at Cincinnati Children’s and around the world to develop innovative treatments for children with kidney cancer. Areas of research include:

  • Developing new anticancer drugs and targeted radiation therapies
  • Understanding why some tumors grow and spread to other parts of the body
  • Understanding how cell molecules work together to fight kidney cancer or cause it to spread
  • Developing new genetic testing technologies to improve the way doctors diagnose and treat kidney cancer

Cincinnati Children’s offers many clinical research opportunities for children with kidney tumors. Some of our advanced experimental therapies may be an option for children whose kidney tumor does not respond to therapy or comes back after treatment.

Many of our advanced therapies are available through our participation in national and international research studies. Some of the anticancer treatments we offer are available here years before they are widely available. Our team works closely with the Children’s Oncology Group, which operates the nation’s largest portfolio of clinical trials for pediatric cancer, and the National Cancer Institute’s new Pediatric Phase I Consortium. We are the only hospital in Ohio, and one of just a few nationwide, to offer pediatric Phase I clinical trials of the newest cancer therapies.

View a list of current clinical trials: